# NHS Trusts Dispute Palantir AI Benefit Claims Twenty-nine hospital trusts report no active usage despite NHS claims of platform benefits. - **Source:** [Technology | The Guardian](https://www.theguardian.com/uk/technology) - **Published:** 2026-11-02 - **Topic:** [Business](https://brifing.si/c/business) - **Original article:** - **On Brifing:** https://brifing.si/s/0870073c-990d-436a-a8b9-68f8487280f4 ## Discrepancy in Adoption Metrics NHS England publicly lists 29 hospital trusts as realizing benefits from the £330m Federated Data Platform. However, these specific trusts report that the system is either not live or entirely unused. This gap between official government claims and local hospital feedback has been labeled as highly misleading by senior health officials. ## Platform Implementation Status Freedom of Information requests reveal that institutions like Nottingham University Hospitals have no agreed implementation timeline. Others, such as the University Hospitals of North Midlands, explicitly stated they do not intend to roll out the platform. These responses directly contradict the official NHS designation of these sites as active beneficiaries. ## Questionable Performance Claims NHS England previously claimed 117,539 additional operations were performed due to the platform. However, the organization conceded it could not prove direct cause and effect. The Office for Statistics Regulation is now investigating these claims, following concerns that the data used to defend the controversial contract lacks sufficient empirical support. ## Infrastructure vs Operational Use NHS England argues that some trusts are listed as live because infrastructure exists for data submission, even if they lack active operational use of platform applications. For example, Torbay and South Devon Trust uses the system for back-office data analysis rather than direct patient care, complicating the definition of platform benefits. ## Political and Ethical Scrutiny The contract faces intense pressure from MPs and campaigners calling for its termination by the 2027 break clause. Critics highlight Palantir’s history with the Israeli military and US homeland security. Concerns persist regarding the influence of founder Peter Thiel and the potential for long-term vendor lock-in within critical public health infrastructure. ## Corporate Lobbying Efforts Palantir has intensified its defense by hiring former Labour deputy leader Tom Watson as a senior lobbyist. Watson has actively engaged in social media campaigns to debunk myths and has sent letters to critical MPs. This aggressive lobbying strategy has drawn comparisons to surveillance tactics, further fueling public and political skepticism. ## Calls for UK-Based Alternatives Chi Onwurah, chair of the Commons science and technology committee, has urged the government to launch an open competition for a UK-owned supplier. The goal is to manage patient records through a system that aligns better with public trust and evidence-based healthcare, moving away from the current reliance on US-based tech. ## Need for Transparent Reporting Marc Farr, chair of the NHS Chief Data and Analytics Officers Network, emphasized that public support depends on accurate, transparent, and verifiable reporting. The current misalignment between central claims and local reality undermines the credibility of the entire digital transformation project, necessitating a rigorous audit of how platform benefits are measured. ## Sources covering this story - https://www.theguardian.com/technology/2026/nov/02/palantir-unused-nhs-hospital-trusts — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._